Globus Medical (GMED) EBIAT (2011 - 2026)

Globus Medical (GMED) has 16 years of EBIAT data on file, last reported at $124.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT rose 64.72% year-over-year to $124.3 million; the trailing twelve-month figure through Mar 2026 stood at $586.7 million (up 216.18% YoY), and the FY2025 full-year result was $537.9 million, up 422.28% from the prior year.
• EBIAT for Q1 2026 stood at $124.3 million, down from $140.6 million in the prior quarter.
• Across five years, EBIAT topped out at $202.8 million in Q2 2025 and bottomed at -$7.1 million in Q1 2024.
• The 5-year median for EBIAT is $50.1 million (2022), against an average of $63.4 million.
• Peak annual rise in EBIAT reached 5093.99% in 2024, while the deepest fall reached 114.49% in 2024.
• A 5-year view of EBIAT shows it stood at $50.1 million in 2022, then plunged by 69.97% to $15.0 million in 2023, then jumped by 76.3% to $26.5 million in 2024, then jumped by 430.44% to $140.6 million in 2025, then dropped by 11.59% to $124.3 million in 2026.
• The last three EBIAT figures came in at $124.3 million (Q1 2026), $140.6 million (Q4 2025), and $119.0 million (Q3 2025), per Business Quant data.

Peer Comparison